Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 434Osteosarcoma 131Sarcoma, Ewing 89Melanoma 81Rhabdomyosarcoma 78Neoplasms 70Gastrointestinal Stromal Tumors 63Neuroblastoma 62Bone Neoplasms 62Colorectal Neoplasms 60Breast Neoplasms 60Ovarian Neoplasms 58Glioblastoma 55Neoplasm Metastasis 52Liposarcoma 49Dendritic Cell Sarcoma, Interdigitating 44Carcinoma, Non-Small-Cell Lung 44Gliosarcoma 42Stomach Neoplasms 40Pancreatic Neoplasms 40Leiomyosarcoma 40Lymphoma 37Glioma 35Carcinoma, Renal Cell 35Sarcoma, Synovial 34Rhabdoid Tumor 34Neurofibrosarcoma 34Uterine Cervical Neoplasms 33Sarcoma, Kaposi 33Lymphoma, Non-Hodgkin 33

Interventions

Pharmacogenomic Testing 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Chondrosarcoma, Clear Cell × Sarcoma × 1 year × Clear all
NCT01267955 2026-04-13

Vismodegib in Treating Patients With Advanced Chondrosarcomas

National Cancer Institute (NCI)

Phase 2 Active not recruiting
45 enrolled 10 charts
Sarcoma

Chondrosarcoma, Clear Cell, Chondrosarcoma, Chondrosarcoma, Mesenchymal

NCT07360964 2026-01-22

CIRCLE

Istituto Ortopedico Rizzoli

Phase NA Active not recruiting
77 enrolled
Sarcoma

Chondrosarcoma, Clear Cell, Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡